✦ LIBER ✦

Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study

✍ Scribed by Giuseppe Patti; Annunziata Nusca; Fabio Mangiacapra; Laura Gatto; Andrea D'Ambrosio; Germano Di Sciascio

Book ID: 119267687
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 301 KB
Volume: 52
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2008.06.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Usefulness of Platelet Response to Clopi

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)

✍ Giuseppe Patti; Vincenzo Pasceri; Vincenzo Vizzi; Elisabetta Ricottini; Germano 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 689 KB

A Therapeutic Window for Platelet Reacti

A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty–Platelet Reactivity for Outcome Validation Effort) Study

✍ Fabio Mangiacapra; Giuseppe Patti; Emanuele Barbato; Aaron J. Peace; Elisabetta 📂 Article 📅 2012 🏛 American College of Cardiology 🌐 English ⚖ 954 KB

Randomized Trial of High Loading Dose of

Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of Myocardial Damage during Angioplasty) Study

✍ G. Patti; G. Colonna; V. Pasceri; L.L. Pepe; A. Montinaro; G. Di Sciascio 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Outcome Comparison of 600- and 300-mg Lo

Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Results From the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Randomized Study

✍ Giuseppe Patti; György Bárczi; Dejan Orlic; Fabio Mangiacapra; Giuseppe Colonna; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 781 KB

Effectiveness of In-Laboratory High-Dose

Effectiveness of In-Laboratory High-Dose Clopidogrel Loading Versus Routine Pre-Load in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Randomized Trial

✍ Germano Di Sciascio; Giuseppe Patti; Vincenzo Pasceri; Laura Gatto; Giuseppe Col 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Antiplatelet effect of 600- and 300-mg l

Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study

✍ Fabio Mangiacapra; Giuseppe Patti; Emanuele Barbato; Dejan Orlic; Aaron J. Peace 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 170 KB